Literature DB >> 2312668

Natural killer cell-mediated lysis of Mycobacterium-avium complex-infected monocytes.

P Katz1, H Yeager, G Whalen, M Evans, R P Swartz, J Roecklein.   

Abstract

Since the precise mechanism of host responses to infection with Mycobacterium-avium complex (MAC) is unclear and since cytotoxic lymphocytes may be involved in the destruction of cells infected with intracellular pathogens, we investigated the ability of normal peripheral blood lymphocytes to kill MAC-infected monocytes in a short-term isotope release assay. Nylon wool-passed lymphocytes lysed MAC-infected but not uninfected monocytes during a 4-hr assay. Infected monocytes were less sensitive to cell-mediated killing than the standard natural killer (NK) cell-sensitive cell line K562, although the kinetics of lysis were similar. The release of lymphocyte-derived mediators such as tumor necrosis factor, interleukin-2 (IL-2), and interferon-alpha and -gamma could not be implicated as a cause of monocyte death. Through the use of cell-specific monoclonal antibodies plus complement, the phenotype of the effector cell was that of an NK cell (CD3 negative, partially CD8 negative, and CD16 positive). The use of highly purified, negatively selected NK cells confirmed these results. NK cell-mediated lysis of infected monocytes decreased MAC viability, indicating that this cytotoxic activity would not favor dissemination of the organism. The killing of MAC-infected monocytes was reduced by K562 cells, suggesting that these targets shared common recognition/binding structures. These results suggest that NK-cell function may be important in the prevention of or response to MAC infection and may help explain the predilection of AIDS patients to develop widespread disease.

Entities:  

Mesh:

Year:  1990        PMID: 2312668     DOI: 10.1007/bf00917500

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  15 in total

1.  Suppression of B cell responses by natural killer cells is mediated through direct effects on T cells.

Authors:  P Katz; S R Mitchell; T R Cupps; M Evans; G Whalen
Journal:  Cell Immunol       Date:  1989-03       Impact factor: 4.868

2.  The histopathology of the acquired immune deficiency syndrome.

Authors:  C Urmacher; S Nielsen
Journal:  Pathol Annu       Date:  1985

Review 3.  Current concepts. Treatment of infections associated with human immunodeficiency virus.

Authors:  A E Glatt; K Chirgwin; S H Landesman
Journal:  N Engl J Med       Date:  1988-06-02       Impact factor: 91.245

4.  Disseminated atypical mycobacterial infection in hairy cell leukemia.

Authors:  J H Gallo; G A Young; P R Forrest; P C Vincent; F Jennis
Journal:  Pathology       Date:  1983-07       Impact factor: 5.306

5.  Resistance of various strains of mycobacteria to killing by activated macrophages in vivo.

Authors:  I M Orme; F M Collins
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

6.  Natural cytotoxic effector cell activity against Shigella flexneri-infected HeLa cells.

Authors:  G R Klimpel; D W Niesel; K D Klimpel
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

7.  Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.

Authors:  B Bonavida; J Katz; M Gottlieb
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

8.  Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.

Authors:  L E Bermudez; L S Young
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

9.  Lysis of murine macrophages infected with intracellular pathogens by interleukin 2-activated killer (LAK) cells in vitro.

Authors:  M Resnick; N Roguel; H Bercovier; C Enk; S Frankenburg; E Kedar
Journal:  Cell Immunol       Date:  1988-04-15       Impact factor: 4.868

10.  Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.

Authors:  P D Smith; K Ohura; H Masur; H C Lane; A S Fauci; S M Wahl
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

View more
  20 in total

Review 1.  Interferons 1992. How much of the promise has been realised?

Authors:  M A Volz; C H Kirkpatrick
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

Review 2.  Immunobiology of Mycobacterium avium infection.

Authors:  L E Bermudez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 3.  Natural killer (NK) cells in antibacterial innate immunity: angels or devils?

Authors:  Fernando Souza-Fonseca-Guimaraes; Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

4.  Leukocyte-mediated lysis of infected hepatocytes during listeriosis occurs in mice depleted of NK cells or CD4+ CD8+ Thy1.2+ T cells.

Authors:  J W Conlan; P L Dunn; R J North
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

5.  The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.

Authors:  Stephanie M Dillon; Eric J Lee; Julia M Bramante; Edward Barker; Cara C Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

6.  Non-major histocompatibility complex-restricted cytotoxic activity of blood mononuclear cells stimulated with secreted mycobacterial proteins and other mycobacterial antigens.

Authors:  P Ravn; B K Pedersen
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Inflammasomes Coordinate Pyroptosis and Natural Killer Cell Cytotoxicity to Clear Infection by a Ubiquitous Environmental Bacterium.

Authors:  Vivien I Maltez; Alan L Tubbs; Kevin D Cook; Youssef Aachoui; E Liana Falcone; Steven M Holland; Jason K Whitmire; Edward A Miao
Journal:  Immunity       Date:  2015-11-10       Impact factor: 31.745

8.  Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium.

Authors:  L E Bermudez; M Wu; L S Young
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 9.  Mycobacterium avium complex: advances in therapy.

Authors:  D V Havlir
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 10.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.